Related Case Studies
The Case is Made for New CPT Codes
A ground-breaking medical device, although recognized by major clinical compendia, was lacking the appropriate Current Procedural Terminology (CPT) codes. This created hesitancy among providers, who feared they would not be reimbursed or prescribing this supportive care technology for their patients.
A Successful Transition from Europe to the US Market
To ensure broad access for their supportive care technology, a European-based medical device company looking to enter the US market sought guidance and support in understanding the US payer system and how to gain buy-in from US healthcare providers.
A First of its Kind Approval Changes the Way We Think About Access
A clinical-stage pharmaceutical company faced a unique barrier in bringing its first product to market—seeking pan-tumor approval based on a genetic marker, rather than a traditional approval based on cancer type. They subsequently sought recognition for the product across relevant clinical compendia.
View All Case Studies
- Healthcare policy changes interpreted in real-time
- A comprehensive launch strategy leads to broad access
- Understanding the European Market
- Insight into a new therapeutic landscape
- Strategizing a change in a company’s focus
- A novel therapy seeks to support physician reimbursement
- The Case is Made for New CPT Codes
- A Successful Transition from Europe to the US Market
- A First of its Kind Approval Changes the Way We Think About Access
